Stem cell therapy for parkinson's disease: A road map for a successful future

Román Vidaltamayo; José Bargas; Luis Covarrubias; Arturo Hernández; Elvira Galarraga; Gabriel Gutiérrez-Ospina; René Drucker-Colin

doi:10.1089/scd.2009.0205

Stem cell therapy for parkinson's disease: A road map for a successful future

Román Vidaltamayo, José Bargas, Luis Covarrubias, Arturo Hernández, Elvira Galarraga, Gabriel Gutiérrez-Ospina, René Drucker-Colin

Research output: Contribution to journal › Review article › peer-review

14 Citations (Scopus)

Abstract

Cell transplant therapy for Parkinson's disease (PD) has been in use for over 2 decades as an experimental treatment. Different cell types have been proposed as better therapeutic alternatives. However, source availability and therapeutic value of the transplants as compared to current pharmacological options have precluded the use of this kind of surgery in the majority of PD patients. In this article, we discuss the suitability of different types of stem cells for PD therapy, the requirements that the donor cells should fulfill in order to improve upon current methods, and propose alternatives for evaluating the efficacy of PD cell therapy.

Original language	English
Pages (from-to)	311-319
Number of pages	9
Journal	Stem Cells and Development
Volume	19
Issue number	3
DOIs	https://doi.org/10.1089/scd.2009.0205
Publication status	Published - 1 Mar 2010
Externally published	Yes

Bibliographical note

Copyright:
Copyright 2010 Elsevier B.V., All rights reserved.

All Science Journal Classification (ASJC) codes

Hematology
Developmental Biology
Cell Biology

Access to Document

10.1089/scd.2009.0205

https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=77949615900&origin=inward

Cite this

@article{a8a6e4aebe19425a893f72be8eccfe87,

title = "Stem cell therapy for parkinson's disease: A road map for a successful future",

abstract = "Cell transplant therapy for Parkinson's disease (PD) has been in use for over 2 decades as an experimental treatment. Different cell types have been proposed as better therapeutic alternatives. However, source availability and therapeutic value of the transplants as compared to current pharmacological options have precluded the use of this kind of surgery in the majority of PD patients. In this article, we discuss the suitability of different types of stem cells for PD therapy, the requirements that the donor cells should fulfill in order to improve upon current methods, and propose alternatives for evaluating the efficacy of PD cell therapy.",

author = "Rom{\'a}n Vidaltamayo and Jos{\'e} Bargas and Luis Covarrubias and Arturo Hern{\'a}ndez and Elvira Galarraga and Gabriel Guti{\'e}rrez-Ospina and Ren{\'e} Drucker-Colin",

year = "2010",

month = mar,

day = "1",

doi = "10.1089/scd.2009.0205",

language = "English",

volume = "19",

pages = "311--319",

journal = "Stem Cells and Development",

issn = "1547-3287",

publisher = "Mary Ann Liebert Inc.",

number = "3",

}

TY - JOUR

T1 - Stem cell therapy for parkinson's disease: A road map for a successful future

AU - Vidaltamayo, Román

AU - Bargas, José

AU - Covarrubias, Luis

AU - Hernández, Arturo

AU - Galarraga, Elvira

AU - Gutiérrez-Ospina, Gabriel

AU - Drucker-Colin, René

PY - 2010/3/1

Y1 - 2010/3/1

N2 - Cell transplant therapy for Parkinson's disease (PD) has been in use for over 2 decades as an experimental treatment. Different cell types have been proposed as better therapeutic alternatives. However, source availability and therapeutic value of the transplants as compared to current pharmacological options have precluded the use of this kind of surgery in the majority of PD patients. In this article, we discuss the suitability of different types of stem cells for PD therapy, the requirements that the donor cells should fulfill in order to improve upon current methods, and propose alternatives for evaluating the efficacy of PD cell therapy.

AB - Cell transplant therapy for Parkinson's disease (PD) has been in use for over 2 decades as an experimental treatment. Different cell types have been proposed as better therapeutic alternatives. However, source availability and therapeutic value of the transplants as compared to current pharmacological options have precluded the use of this kind of surgery in the majority of PD patients. In this article, we discuss the suitability of different types of stem cells for PD therapy, the requirements that the donor cells should fulfill in order to improve upon current methods, and propose alternatives for evaluating the efficacy of PD cell therapy.

UR - http://www.scopus.com/inward/record.url?scp=77949615900&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77949615900&partnerID=8YFLogxK

UR - https://www.mendeley.com/catalogue/a0660239-0cfa-3ef9-ba8c-8706e84d46d6/

U2 - 10.1089/scd.2009.0205

DO - 10.1089/scd.2009.0205

M3 - Review article

SN - 1547-3287

VL - 19

SP - 311

EP - 319

JO - Stem Cells and Development

JF - Stem Cells and Development

IS - 3

ER -

Stem cell therapy for parkinson's disease: A road map for a successful future

Abstract

Bibliographical note

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Fingerprint

Cite this